New drugs are being introduced in the US market at over-the-top prices. In November, regulators in the United States approved the most expensive drug in the world. CSL's Hemgenix, a gene therapy for the blood-clotting disorder hemophilia B, made its debut with a list price of $3.5 million for one treatment.